Panel Boosts Therapeutic Monitoring of IBD Drug: Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D.

Answers from the Lab

Innhold levert av Mayo Clinic Laboratories. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Mayo Clinic Laboratories eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

1M ago 9:46

MP3•Episoder hjem

Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D., explain how Mayo Clinic Laboratories' unique risankizumab panel measures levels of both that drug and its antibodies in patients' blood. The results can better guide the management of patients with inflammatory bowel disease.

Speaker 4: (00:32)
Please give the audience a little information about yourself and your background.

Speaker 4: (02:12)
Please give the audience a brief overview of this assay.

Speaker 4: (04:34)
Which patients should have this testing and when should it be performed?

Speaker 4: (05:50)
What alternative testing options are available and how do these compare?

Speaker 4: (06:47)
How are the results used in patient care?

320 episoder

#Science #Fitness #Medicine #Mayo Clinic Podcast For Laboratory #Laboratory Medicine #Healthcare #Lab #Mayo Clinic #Clinical #Dlmp #Morice #Pritt